INVO Fertility, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
INVO Fertility, Inc. (IVF) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 3.69% for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2025-04-30
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2023-03-31 was 3.63%, a 91.05% increase year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2022-03-31 was 1.90%, a 512.90% increase year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2021-03-31 was 0.31%, a 81.21% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2020-03-31 was 1.65%.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2023 was 3.69%, a 6.35% decline from fiscal 2022.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2022 was 3.94%, a 439.73% increase from fiscal 2021.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2021 was 0.73%, a 55.76% decline from fiscal 2020.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2020 was 1.65%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|---|---|---|
| 2023-12-31 | 3.69% 10-K · filed 2025-04-30 | |||
| 2023-09-30 | 3.69% 10-Q · filed 2024-11-19 | |||
| 2023-06-30 | 3.69% 10-Q/A · filed 2024-11-19 | |||
| 2023-03-31 | 3.63% 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | 3.94% 10-K/A · filed 2024-11-19 | |||
| 2022-09-30 | 1.90% 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | 1.90% 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | 1.90% 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | 0.73% 10-K · filed 2023-04-17 | |||
| 2021-09-30 | 0.73% 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | 0.73% 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | 0.31% 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | 1.65% 10-K · filed 2022-03-31 | |||
| 2020-09-30 | 1.65% 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | 1.65% 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | 1.65% 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |